Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis

European Respiratory Journal

Volumn 20, Issue 1, 2002, Pages 92-99

  Zetterquist, W ^a   Marteus, H ^a   Johannesson, M ^a   Nordvall, S L ^a   Ihre, E ^a   Lundberg, J O N ^a   Alving, K ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Allergic rhinitis; Asthma; Carbon monoxide; Cystic fibrosis; Exhaled air; Nitric oxide

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CARBON MONOXIDE; EXPECTORANT AGENT; NITRIC OXIDE; STEROID;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ANALYTIC METHOD; ARTICLE; ASTHMA; BREATH HOLDING; CHEMOLUMINESCENCE; CHILD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYSTIC FIBROSIS; ELECTROCHEMICAL ANALYSIS; EXHALATION; EXPIRATORY FLOW RATE; FEMALE; HUMAN; LUNG ALVEOLUS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; RESIDUAL VOLUME; RESPIRATORY TRACT INFLAMMATION; TIDAL VOLUME; TIME; BREATH ANALYSIS; COMPARATIVE STUDY; ELECTROCHEMISTRY; FRACTIONATION; HAY FEVER; INSTRUMENTATION; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; ASTHMA; BREATH TESTS; BRONCHODILATOR AGENTS; CARBON MONOXIDE; CHEMICAL FRACTIONATION; CHEMILUMINESCENCE; CHILD; COMPARATIVE STUDY; CYSTIC FIBROSIS; ELECTROCHEMISTRY; FEMALE; HAY FEVER; HUMAN; MALE; MIDDLE AGE; NITRIC OXIDE; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; CHEMILUMINESCENT MEASUREMENTS; HUMANS; MIDDLE AGED; RHINITIS, ALLERGIC, SEASONAL;

EID: 0035989337     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.02.00245302     Document Type: Article

References (32)

1. Increased amount of nitric oxide in exhaled air of asthmatics
2. Exhaled nitric oxide: A new lung function test
3. Nitric oxide in exhaled air
4. Clinical aspects of exhaled nitric oxide
5. Increased carbon monoxide in exhaled air of asthmatic patients
6. Increased levels of exhaled carbon monoxide in bronchiectasis: A new marker of oxidative stress
7. Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: A new marker of oxidative stress
8. Increased carbon monoxide in exhaled air of patients with cystic fibrosis
9. Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma
10. Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis
11. Exhaled carbon monoxide in childhood asthma
12. Relation between exhaled carbon monoxide levels and clinical severity of asthma
13. American Thoracic Society official statement: Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children - 1999
14. Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis
15. Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis
16. Exhaled nitric oxide in paediatric asthma and cystic fibrosis
17. Increased carbon monoxide in exhaled air of subjects with upper respiratory tract infections
18. Exhaled monoxides in asymptomatic atopic subjects
19. Induction of nitric oxide synthase in asthma
20. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group
21. Heme oxygenase-1: Function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury
22. Expression of heme oxygenase isoenzymes 1 and 2 in normal and asthmatic airways. Effect of inhaled corticosteroids
23. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide
24. Flow-dependency of exhaled nitric oxide in children with asthma and cystic fibrosis
25. Reduced upper airway nitric oxide in cystic fibrosis
26. Endogenous nitric oxide in single exhalations and the change during exercise
27. Effect of chronic airways obstruction on measurement of the single-breath carbon-monoxide-diffusing capacity
28. Uptake and elimination of exhaled carbon monoxide in patients with interstitial lung disease is related to the degree of impairment of carbon monoxide diffusion capacity
29. A simultaneous single breath measurement of pulmonary diffusing capacity with nitric oxide and carbon monoxide
30. Pulmonary diffusing capacity for carbon monoxide and nitric oxide
31. Identification of the subcellular site for nitroglycerin metabolism to nitric oxide in bovine coronary smooth muscle cells
32. Nitric oxide: Delivery, measurement, and clinical application